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The 22q11.2 deletion is the strongest known genetic risk factor for schizophrenia.
Research has implicated microRNA-mediated dysregulation in 22q11.2 deletion syndrome
(22q11.2DS) schizophrenia-risk. Primary candidate genes are DGCR8 (DiGeorge syndrome
critical region gene 8), which encodes a component of the microprocessor complex
essential for microRNA biogenesis, and MIR185, which encodes microRNA 185. Mouse
models of 22q11.2DS have demonstrated alterations in brain microRNA biogenesis,
and that DGCR8 haploinsufﬁciency may contribute to these alterations, e.g., via down-
regulation of a speciﬁc microRNA subset. miR-185 was the top-scoring down-regulated
microRNA in both the prefrontal cortex and the hippocampus, brain areas which are the
key foci of schizophrenia research. This reduction in miR-185 expression contributed to
dendritic and spine development deﬁcits in hippocampal neurons. In addition, miR-185
has two validated targets (RhoA, Cdc42), both of which have been associated with altered
expression levels in schizophrenia. These combined data support the involvement of miR-
185 and its down-stream pathways in schizophrenia. This review summarizes evidence
implicating microRNA-mediated dysregulation in schizophrenia in both 22q11.2DS-related
and idiopathic cases.
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INTRODUCTION
The 22q11.2 deletion syndrome (22q11.2DS), also known as
the velocardiofacial/DiGeorge syndrome, is a phenotypically het-
erogenous disease which is caused by a hemizygous microdeletion
on the long arm of chromosome 22 in the region q11.2. The over-
all prevalence is 1 in 2,000–4,000 live births (Murphy et al., 1999;
Botto et al., 2003; Robin and Shprintzen, 2005). The disorder is
associated with a high risk for psychiatric disorder.
In particular, 22q11.2DS patients have an estimated 20–25%
risk for schizophrenia or related psychotic disorders such as
schizoaffective disorder (Murphy et al., 1999; Chow et al., 2006;
Bassett and Chow, 2008; Philip and Bassett, 2011). The dele-
tion is therefore the strongest known genetic risk factor for
schizophrenia (odds ratio = 20.3; Levinson et al., 2011), and
accounts for approximately 1–2% of all schizophrenia cases
(Karayiorgou et al., 1995, 2010; Bassett and Chow, 2008; Interna-
tional Schizophrenia Consortium, 2008; Stefansson et al., 2008).
Individuals with 22q11.2DS have variable cognitive and behav-
ioral deﬁcits (Karayiorgou et al., 2010) including relative impair-
ments in social judgment, motor skills, verbal learning, and
executive functioning (Chow et al., 2006; Philip and Bassett,
2011). In addition, adults with a 22q11.2 microdeletion have
a two- to threefold increase in the risk of generalized anxiety
disorder compared to the general population (Philip and Bas-
sett, 2011). The major clinical features of 22q11.2DS-related
schizophrenia are largely indistinguishable from those of the
idiopathic disease (Murphy et al., 1999; Chow et al., 2006;
Bassett and Chow, 2008). Identiﬁcation of schizophrenia-risk
gene/s in the 22q11.2DS deletion region may therefore gener-
ate insights into the pathophysiology of schizophrenia in general
(Earls et al., 2012).
The size of the 22q11.2 deletion varies. The majority of 22q11.2
deletions (around 90%) are 3 Mb in size and span approximately
60 known genes, while the remaining 10% are 1.5 Mb in size and
encompass around 35 genes (Edelmann et al., 1999; Shaikh et al.,
2000). Both the larger and the smaller 22q11.2 microdeletions
usually result from non-allelic homologous recombination, which
is mediated by ﬂanking low-copy repeats (Edelmann et al., 1999).
Although the 22q11.2DS phenotype is highly variable, its severity
is not correlated with the size of the deletion. This suggests that
the minimal 1.5 Mb deletion region is crucial in terms of etiology
(Carlson et al., 1997; Karayiorgou et al., 2010).
Initial research to identify schizophrenia-risk genes in the
22q11.2 deletion region proved unsuccessful. The identiﬁca-
tion of heterozygous loss-of-function mutations in non-deleted
schizophrenia patients would be the most obvious human genetic
evidence for the involvement of a speciﬁc gene in disease suscep-
tibility. Hopes were raised by the identiﬁcation of heterozygous
point mutations in the T-box 1 gene (TBX1), which encodes
a T-box transcription factor, that resulted in the characteristic
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abnormal facies and cardiac defects of 22q11.2DS in patients with-
out a 22q11.2 deletion (Yagi et al., 2003; Zweier et al., 2007). How-
ever, no such mutation has yet been identiﬁed in schizophrenia
patients.
In contrast, recent research in the Df(16)A+/− mouse model
has generated breakthroughs in our understanding of the underly-
ing biological mechanisms of 22q11.2DS schizophrenia-risk. This
engineered mouse strain carries a heterozygous chromosomal
deletion which spans a segment syntenic to the human 22q11.2
locus. Df(16)A+/− mice show deﬁcits in the synaptic connectivity
of hippocampal neurons, including a lower density of dendritic
spines and glutamatergic synapses (Mukai et al., 2008). In addi-
tion, Df(16)A+/− mice display hyperactive behavior and deﬁcits
in spatialworkingmemory-dependent learning (Stark et al., 2008).
Further characterization of this animal model has suggested that
the 22q11.2 microdeletion results in alterations in the biogenesis
of brain microRNAs (Stark et al., 2008; Xu et al., 2010). Primary
candidate genes in the region are the DiGeorge syndrome critical
region gene 8 (DGCR8), which encodes a component of themicro-
processor complex essential formicroRNAbiogenesis (Tomari and
Zamore, 2005), and the MIR185 gene (Karayiorgou et al., 2010),
which encodes microRNA 185. Both genes are located within the
minimal 1.5 Mb deletion region at 22q11.2 (Karayiorgou et al.,
2010).
The microRNAs are a class of 21–25-nucleotide small
non-coding RNAs. They control the expression of their target
genes by binding to target sites inmessenger RNAs (mRNAs), typi-
cally in their 3′ untranslated regions (He andHannon,2004; Meola
et al., 2009). In most cases, microRNAs negatively regulate target
gene expression through a combination of repression of mRNA
translation and promotion of mRNA decay. Each microRNA usu-
ally controls up to several hundred target mRNAs, while one
mRNA target can be synergistically regulated by multiple microR-
NAs (Sathyan et al., 2007; Didiano and Hobert, 2008; Drew et al.,
2011). This allows microRNAs to integrate different intracellular
signals and to regulate various signaling pathways (Johnston and
Hobert, 2003; Choi et al., 2007). Accumulating evidence suggests
that microRNAs contribute to the basic mechanisms underly-
ing brain development and plasticity (Table 1; Fineberg et al.,
2009; Schratt, 2009; Im and Kenny, 2012). Neural microRNAs
play an important role at various stages of synaptic development,
including dendritic arborization (Vo et al., 2005; Yu et al., 2008),
synapse formation, and synapsematuration (Caygill and Johnston,
2008; Siegel et al., 2009). Arguably the two most extensively stud-
ied examples in the context of synapse development are miR-132
and miR-134. CREB-induced miR-132 promotes dendritogenesis
and spine growth by down-regulating p250GAP (Wayman et al.,
2008; Magill et al., 2010). miR-134 on the other hand is required
for activity-dependent dendritic arborization and the restriction
of spine growth by targeting Pumilio-2 and Lim-domain con-
taining protein kinase (Limk1), respectively (Schratt et al., 2006;
Fiore et al., 2009). Furthermore, investigation of a mouse model
displaying conditional knock-out of the microRNA biogenesis
enzyme Dicer (Schratt, 2009) revealed disrupted morphogenesis
of the hippocampus and cortex (Davis et al., 2008), suggest-
ing that undisturbed microRNA processing might be necessary
for normal brain development (Xu et al., 2010). These data
suggest the possible involvement of microRNA-dependent dys-
regulation in the pathogenesis of various psychiatric disorders
(Forero et al., 2010; Xu et al., 2010), including schizophrenia
(Beveridge et al., 2008).
The present review summarizes the various lines of evidence
implicating microRNAs as the causal factor for schizophrenia
in 22q11.2DS carriers and emerging evidence from expression
studies and genome-wide association studies (GWAS) that these
mechanismsmay also be involved in the development of idiopathic
schizophrenia.
THE ROLE OF DGCR8
Investigation of Dgcr8+/− mice conﬁrmed that heterozygous
Dgcr8 deﬁciency was responsible for the reduced biogenesis of
microRNAs observed in Df(16)A+/− mice (Stark et al., 2008;
Schoﬁeld et al., 2011). Dgcr8+/− mice displayed 22q11.2DS-
associated cognitive andbehavioral deﬁcits, and altered short-term
plasticity in the prefrontal cortex (PFC; Stark et al., 2008). This
indicates that DGCR8 heterozygosity, and the resulting alter-
ations in microRNA expression, are sufﬁcient to produce some
of the neural deﬁcits observed in 22q11.2DS (Schoﬁeld et al.,
2011). On the neuronal cell level, Dgcr8 deﬁciency resulted in
structural changes in dendritic spines and reduced dendritic com-
plexity in the hippocampus (Stark et al., 2008). Schoﬁeld et al.
(2011) identiﬁed alterations in the electrical properties of layer
V pyramidal neurons in the medial PFC of Dgcr8+/− mice,
as well as a decrease in the complexity of the basal dendrites
and reduced excitatory synaptic transmission. These functional
results suggest that precise microRNA expression is critical for
the development of PFC circuitry (Schoﬁeld et al., 2011), circuitry
which has been reported to be altered in schizophrenia patients
(Ursu et al., 2011).
Dgcr8+/− mice also displayed a decrease in the number of cor-
tical neurons, structural deﬁcits in dendritic spines in the PFC,
and alterations in synaptic potentiation and short-term plasticity
(Fenelon et al., 2011). These alterationsmight inﬂuence functional
connectivity (Schreiner et al., 2013), and could be implicated in the
observed cognitive and behavioral deﬁcits. In particular, they may
explain observed alterations in prepulse inhibition (Stark et al.,
2008), which have also been reported in schizophrenia patients
(Powell et al., 2009).
Ouchi et al. (2013) showed that heterozygous Dgcr8 deﬁciency
in mice led to reduced progenitor cell proliferation and neuro-
genesis in the adult hippocampus. This is of particular interest
since alterations in the anatomy, histology, and function of the
hippocampus have been consistently reported in schizophrenia
patients (Tamminga et al., 2010). Several schizophrenia-associated
genes were down-regulated in the hippocampus of Dgcr8+/−
mice (Ouchi et al., 2013), including the insulin-like growth fac-
tor 2 (IGF2), which was recently found to play a crucial role in
hippocampal functions such as memory consolidation and fear
extinction (Agis-Balboa et al., 2011; Chen et al., 2011a). Interest-
ingly, restoration of IGF2 expression in the hippocampus rescued
the observed spatial working memory deﬁcits in Dgcr8+/− mice,
suggesting that IGF2 contributes – at least in part – to the learn-
ing and spatial working memory deﬁcits that are associated with
22q11.2DS-related schizophrenia (Ouchi et al., 2013).
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Table 1 | List of individual microRNAs involved in neural development and synapse development/plasticity and their mRNA targets in mice and
men.
MicroRNA Function Target/s Reference
microRNAs involved in neural development
let-7 Promotes neuronal differentiation HMGA, LIN28, TLX Nishino et al. (2008), Rybak et al. (2008), Zhao
et al. (2010)
Neural tube closure MLIN41 Maller Schulman et al. (2008)
miR-7a Inhibits differentiation of forebrain dopaminergic
neurons
PAX6 de Chevigny et al. (2012)
miR-9 Promotes neuronal differentiation FOXG1, TLX, STAT3, REST, FGF8,
FGFR1, FOXP2
Krichevsky et al. (2006), Leucht et al. (2008),
Packer et al. (2008), Shibata et al. (2008,
2011), Zhao et al. (2009), Yoo et al. (2011),
Clovis et al. (2012)
Promotes proliferation of early human embryonic
stem cell-derived neural progenitor cells
STMN1 Delaloy et al. (2010)
miR-9* Promotes neuronal differentiation BAF53a Yoo et al. (2009, 2011)
? coREST Packer et al. (2008)
miR-17 Inhibits neural differentiation ? Beveridge et al. (2009)
miR-17/92 Promotes axonal outgrowth in embryonic cortical
neurons
PTEN Zhang et al. (2013)
Controls spinal neural progenitor patterning Olig2 Chen et al. (2011b)
miR-34a Antagonizes neuronal differentiation Numbl Fineberg et al. (2012)
Promotes neuroblastoma and medulloblastoma
differentiation
? Agostini et al. (2011), de Antonellis et al. (2011)
miR-92b Limits the production of intermediate cortical
progenitors
? Nowakowski et al. (2013)
miR-124 Promotes neuronal differentiation SCP1, PTBP1, SOX9, DLX2, JAG1,
BAF53a, RhoG, Lhx2
Makeyev et al. (2007), Visvanathan et al.
(2007), Cheng et al. (2009), Yoo et al. (2009,
2011), Sanuki et al. (2011), Akerblom et al.
(2012), Franke et al. (2012)
miR-125 Promotes neuronal differentiation GLI1, SMO, LIN28, SMAD4 Ferretti et al. (2008), Rybak et al. (2008),
Boissart et al. (2012)
miR-128 Inhibits NSC proliferation BMI1 Godlewski et al. (2008)
miR-132 Promotes synaptic integration and survival of
newborn dentate gyrus and olfactory bulb neurons
Nurr1, FoxP2 Luikart et al. (2011), Clovis et al. (2012),
Pathania et al. (2012)
Promotes differentiation of dopamine neurons Nurr1 Yang et al. (2012)
miR-133b Modulates maturation of dopaminergic neurons PITX3 Kim et al. (2007)
miR-137 Promotes neural differentiation of embryonic stem
cells
Klf4, Tbx3 Jiang et al. (2013)
miR-200 Promotes olfactory progenitor differentiation SOX2, ETF3 Choi et al. (2008), Peng et al. (2012)
miR-324-5p Promotes neuronal differentiation GLI1, SMO Ferretti et al. (2008)
miR-326 Promotes neuronal differentiation GLI1, SMO Ferretti et al. (2008)
miR-541 Promotes neurite outgrowth of PC12 cells Synapsin-1 Zhang et al. (2011)
microRNAs involved in synapse development/plasticity
miR-29a/b Inhibits spine maturation Arpc3 Lippi et al. (2011)
miR-34c Negative constraint of memory consolidation SIRT1 Zovoilis et al. (2011)
(Continued)
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Table 1 | Continued
MicroRNA Function Target/s Reference
miR-124 Regulates neuronal process complexity RhoG, Cdc42 Yu et al. (2008), Franke et al. (2012)
miR-125a Reduces number of branched spines PSD-95 Muddashetty et al. (2011)
miR-125b Negatively regulates spine morphology NR2A Edbauer et al. (2010)





Essential for experience-dependent plasticity
in visual cortex
Negatively regulates circadian clock resetting
P250RhoGap, MeCP2, RFX4 Vo et al. (2005), Cheng et al. (2007), Wayman et al.
(2008), Edbauer et al. (2010), Impey et al. (2010),
Mellios et al. (2011), Tognini et al. (2011), Scott et al.
(2012), Hansen et al. (2013), Remenyi et al. (2013),
Wang et al. (2013)
miR-134 Necessary for activity-dependent
dendritogenesis
Pum2 Fiore et al. (2009)
Restricts spine growth Limk1 Schratt et al. (2006)
Interferes with memory formation and LTP Creb1 Gao et al. (2010)
miR-137 Inhibits dendritic morphogenesis Mib1 Smrt et al. (2010)
miR-138 Negatively regulates dendritic spine size Apt-1 Siegel et al. (2009)
Represses axon regeneration SIRT1 Liu et al. (2013)
miR-146a Inhibits AMPAR endocytosis MAP1B Chen and Shen (2013)
miR-181a Reduces AMPAR expression and spine
formation
GluA2 Saba et al. (2012)
miR-188 Controls dendritic plasticity Nrp-2 Lee et al. (2012)
miR-219 Regulates circadian clock length SCOP Cheng et al. (2007)
miR-375 Reduces dendrite density HuD Abdelmohsen et al. (2010)
miR-483-5p Rescues dendritic spine defects in
MeCP2-overexpressing neurons
MeCP2 Han et al. (2013)
miR-485 Regulates presynaptic homeostatic plasticity Synapsin-1 Cohen et al. (2011)
NSC, neural stem cell; LTP, long-term potentiation; ? – unknown.
The question now arises as to which speciﬁc microRNAs
are regulated by DGCR8. The investigation of Dgcr8+/− mice
identiﬁed 59down-regulatedmicroRNAs in thePFCand30down-
regulated microRNAs in the hippocampus (Stark et al., 2008).
These down-regulated microRNAs include miR-185, which is also
located in the minimal 1.5 Mb deletion region at 22q11.2.
THE ROLE OF MIR185
Studies of 22q11.2DS mouse models have identiﬁed miR-185
as the top-scoring down-regulated microRNA in schizophrenia-
associated brain areas (Stark et al., 2008; Benetti et al., 2009). A
recent study by Xu et al. (2013) conﬁrmed the drastic reduction
in miR-185 expression levels in the hippocampus and PFC of
Df(16)A+/− mice, and showed that this reduction contributed
to deﬁcits in dendritic complexity and spine development in hip-
pocampal neurons. In addition, Dgcr8 deﬁciency resulted in an
approximately 20% reduction in miR-185 expression in the hip-
pocampus (Xu et al., 2013). This suggests that the pronounced
reduction of miR-185 expression in Df(16)A+/− mice – a reduc-
tion which is much more pronounced than would be expected by
the 50% decrease in gene dosage – may be due to the combined
effect of the hemizygosity of the MIR185 gene and the impaired
maturation of the pri-miR-185 transcript secondary to reduced
Dgcr8 levels (Figure 1; Xu et al., 2013). The large reduction in miR-
185 expression renders miR-185 unique among the genes that are
affected by the 22q11.2 microdeletion (Xu et al., 2013).
A recent human study conﬁrmed a down-regulation of MIR185
expression to 0.4× normal levels in the peripheral blood of
patients with 22q11.2DS (de la Morena et al., 2013). This ﬁnding
suggests that pronounced miR-185 down-regulation also occurs
in patients with 22q11.2DS.
Previous research has shown thatMIR185 is present or enriched
in synapses (Lugli et al., 2008; Earls et al., 2012). This may indicate
that MIR185 is of relevance to neural function, since a number
of microRNAs have been shown to play a critical role in synaptic
plasticity (Schratt, 2009).
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FIGURE 1 | Dysregulation of microRNA biogenesis in 22q11.2DS
animal models. The MIR185 and the DGCR8 genes are located within
the minimal 1.5 Mb microdeletion region on chromosome 22q11.2 and the
equivalent region of mouse chromosome 16. The microdeletion leads to a
hemizygosity of MIR185 and DGCR8. The heterozygous Dgcr8 deﬁciency
is responsible for the reduced biogenesis of a speciﬁc subset of
microRNAs (red) observed in Df(16)A+/− mice (Stark et al., 2008). These
down-regulated microRNAs include miR-185 (black). The pronounced
reduction of miR-185 expression (indicated by a broader arrow) may be
due to a combined effect of the hemizygosity of the MIR185 gene and
the impaired maturation of the pri-miR-185 transcript secondary to
reduced Dgcr8 levels (Xu et al., 2013). The resulting alterations in mature
microRNA expression levels may lead to altered gene expression of
target genes, which might produce some of the neural, cognitive, and
behavioral deﬁcits observed in 22q11.2DS. miRISC, microRNA-induced
silencing complex.
Earls et al. (2012) identiﬁed MIR185 as a regulator of
sarco(endo)plasmic reticulum Ca(2+) ATPase (SERCA2) which
maintains Ca2+ levels in the endoplasmatic reticulum. The deple-
tion of MIR185 contributes to SERCA2 upregulation and has
been proposed as a mechanism leading to abnormal hippocampal
synaptic plasticity in 22q11.2DS mouse models. The microRNA
regulation of SERCA2 translation may also be implicated in the
elevation of SERCA2 protein observed in the post-mortem brains
of idiopathic schizophrenia patients (Earls et al., 2012). These
results suggest that microRNA-mediated SERCA2 upregulation at
central synapses might be a mechanistic link between 22q11.2DS
and idiopathic schizophrenia (Earls et al., 2012).
Further support for the involvement of MIR185 in schizophre-
nia is provided by ﬁndings that two of its validated targets (RhoA,
Cdc42; Liu et al., 2011) are associated with altered expression lev-
els in schizophrenia (Hill et al., 2006; Ide and Lewis, 2010). Cdc42
(cell division cycle 42) is a member of the RhoGTPase family
(Hill et al., 2006) and promotes dendritic spine formation (Irie
and Yamaguchi, 2002; Tada and Sheng, 2006; Wegner et al., 2008)
by regulating the polymerization of the actin cytoskeleton into
ﬁlopodia (Nobes and Hall, 1995). Cdc42 is activated by Colly-
bistin/ARHGEF9 (Reid et al., 1999; Reddy-Alla et al., 2010), which
has recently been identiﬁed as a candidate blood biomarker in
psychosis (Kurian et al., 2011). RhoA (Ras homologous member
A) also belongs to the RhoGTPase family and regulates the destabi-
lization of the actin cytoskeleton (Hill et al., 2006). The activation
of RhoA leads to a reduction in the number of dendritic branches
and the density of dendritic spines (Nakayama et al., 2000; Hill
et al., 2006).
EXPRESSION OF microRNAs IN IDIOPATHIC SCHIZOPHRENIA
Post-mortem studies of human brain tissue have revealed alter-
ations in microRNA expression in patients with schizophre-
nia. This research is reviewed elsewhere (Beveridge and Cairns,
2012). Brieﬂy, numerous microRNAs have been implicated in
the disorder across multiple studies, including 16 microRNAs
with increased and 11 microRNAs with decreased expression
(Beveridge and Cairns, 2012). Of particular interest in the
context of the present review is the study by Moreau et al.
(2011). This reported a signiﬁcant overlap between microR-
NAs dysregulated in human post-mortem brain tissue and
microRNAs previously found to be altered in the PFC of
a 22q11.2DS mouse model (Stark et al., 2008; Moreau et al.,
2011). This ﬁnding supports the hypothesis that ﬁndings in
22q11.2DS might be of relevance to idiopathic schizophrenia
(Brzustowicz and Bassett, 2012).
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GWAS OF IDIOPATHIC SCHIZOPHRENIA
The involvement of microRNA-dependent dysregulation in
schizophrenia is supported by the results of the large GWAS
of schizophrenia performed by the Schizophrenia Psychiatric
Genome-Wide Association Study (GWAS) Consortium (2011).
In total 17,836 patients and 33,859 controls were investigated. A
single-nucleotide polymorphism (SNP) in an intron of MIR137
was the second strongest ﬁnding (odds ratio = 1.12). Four other
loci with genome-wide signiﬁcance in this study contained pre-
dicted targets of MIR137 (TCF4, CACNA1C, CSMD1, C10orf26).
All four genes have recently been validated as miR-137 targets
(Kwon et al., 2013).
The miRanda database lists 5,487 genes as targets of miR-137
(John et al., 2004). Interestingly, ZNF804A is listed as a validated
target (Kim et al., 2012a). This gene has shown strong association
with schizophrenia in previous studies (O’Donovan et al., 2008;
Williams et al., 2011). Other promising targets include the ubiq-
uitin ligase Mind bomb one (Mib1; Smrt et al., 2010) which plays
an important role in neurogenesis and neurodevelopment (Itoh
et al., 2003; Choe et al., 2007; Ossipova et al., 2009).
Research in post-mortem brain samples suggests that the func-
tional effect of the miR-137 risk allele may result in a reduced
miR-137 expression (Guella et al., 2013). Further down-stream
this may be responsible for the reduced white matter integrity,
smaller hippocampi, and larger lateral ventricles observed in
schizophrenia patients with the miR-137 risk genotype (Lett et al.,
2013).
CONCLUSION AND OUTLOOK
Strong evidence suggests that microRNA dysregulation is impli-
cated in the development of schizophrenia in 22q11.2DS patients.
This is consistent with the growing recognition of microRNAs
as important regulators of gene expression. As microRNAs inte-
grate different intracellular signals and regulate various signaling
pathways (Johnston and Hobert, 2003; Choi et al., 2007), the dys-
regulation of speciﬁc microRNAs could lead to the heterogenous
phenotype observed in 22q11.2DS.
As summarized above, emerging evidence from expression
and genetic analyses suggests that the same microRNA-regulated
pathways may also play a role in idiopathic schizophrenia. How-
ever, despite a number of systematic investigations of genes
in the 22q11.2DS region and the ever increasing number of
GWAS data sets (Karayiorgou et al., 2010; Sullivan et al., 2012),
no genetic study to date has identiﬁed common variation in
DGCR8 or MIR185 as a risk factor for schizophrenia. This
may simply reﬂect a lack of common functional variants at
these loci. This hypothesis is supported by a recent study of
genetic regulation of microRNA expression (Gamazon et al.,
2012). Gamazon et al. (2012) systematically investigated the rela-
tionship between microRNA expression levels (as quantitative
traits) and common genetic variation. In this study, no SNP
had signiﬁcant cis effects on miR-185 expression. A small num-
ber of SNPs have been reported to have signiﬁcant cis effects
on DGCR8 expression in human monocytes (Zeller et al., 2010),
and ﬁbroblasts (Dimas et al., 2009). However, these associations
might be tissue-speciﬁc, since a recent study of ﬁve different
human post-mortem brain regions failed to identify any SNP
with signiﬁcant cis effects on DGCR8 expression (Kim et al.,
2012b).
A challenge for future research will be to identify and validate
the target genes that are affected by microRNA dysregulation and
their respective pathways in a more comprehensive manner (Drew
et al., 2011). Such research will improve our understanding of how
alterations in microRNA-regulated genetic networks contribute to
the pathophysiology of both 22q11.2DS-related and idiopathic
schizophrenia.
Idiopathic schizophrenia is a multifactorial disorder for which
both genetic and environmental factors exert an impact on dis-
ease susceptibility (Sawa and Snyder, 2002). However, very few
data are available concerning the inﬂuence of environmental fac-
tors on microRNA dysregulation. Recent studies in mice showed
that environmental factors such as stress resulted in alterations of
microRNA expression in the frontal cortex (Rinaldi et al., 2010).
Future studies are therefore warranted to investigate the extent
to which environmental factors are associated with microRNA
dysregulation in schizophrenia.
Further research into the precise role of microRNAs in
schizophrenia is important clinically, since modiﬁcation of
microRNA dysregulation would represent a novel therapeutic
approach to this devastating and chronic disease. MicroRNAs are
excellent candidates for therapy since they regulate multiple tar-
gets in various signaling pathways, thereby minimizing the risk
of resistance development or compensatory mechanisms (Soriano
et al., 2013). This view is supported by several recent studies and
reviews, which have highlighted microRNAs as promising phar-
macological targets in the treatment of complex diseases such as
psychiatric disorders (Im and Kenny, 2012), cancer (Soriano et al.,
2013), and diabetes (Mao et al., 2013).
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